GHI is building a carefully integrated portfolio of investments in six focus areas that are outside of Merck's core pharmaceuticals, vaccines, consumer products, and animal health businesses. As a strategic growth investor, GHI's goal is to grow emerging health care solutions into meaningful businesses. Companies we invest in typically have current revenues, a strong business plan and high growth potential.
Health Solutions & Services
- Flexible Access
Facilitating the delivery of better health outcomes at lower cost in nontraditional sites of care (e.g., home health, mobile health, remote monitoring, point of care diagnostics) - Health Intervention
Enabling better health outcomes for patients and caregivers by better coordinating transitions in care (e.g., wellness, case management, continuum of care management). - Personalized Medicine
Delivering the right treatment to the right patient at the right time (e.g., molecular diagnostics, ‘nomic profiling and decision support)
Health Information Technology
- Health Productivity Enablers
Providing better information connectivity to enable more effective delivery of care (e.g., patient-physician engagement, PHR/EHR, health communities, cloud based solutions) - Health Informatics & Analytics
Transforming data into meaningful information that produces better health care decisions (e.g., clinical decision support, post-market informatics) - Health Data Liberation
Enabling better health data aggregation, harmonization and integration (e.g., privacy and security, data aggregation, data scrubbing)